INVO Bioscience, Inc. (INVO)

0.9989 -0.0061 (-0.61%) At close: 04:00PM EDT

INVO Bioscience, Inc.

5582 Broadcast Court
Sarasota, FL 34240
United States
978 878 9505
https://www.invobio.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 10

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Steven M. Shum	CEO & Director	297.5k	N/A	1971
Mr. Andrea Goren	Chief Financial Officer	517.34k	N/A	1967
Mr. Michael Jos. Campbell	COO & VP of Bus. Devel.	330k	N/A	1958
Dr. Kevin Doody M.D.	Medical Director & Director	25k	N/A	1959
Mr. Bojan Mitrovic Ph.D.	Director of Sales US	N/A	N/A	N/A
Dr. Barbara Levy F.A.C.S., FACOG, M.D.	Sr. VP of Global Clinical Integration	N/A	N/A	N/A
Mr. Chris Myer	Sr. VP of Bus. Devel. of Americas	N/A	N/A	N/A
Mr. Robert Joseph Bowdring Jr.	Treasurer & Sec.	N/A	N/A	1958
Ms. Terah Krigsvold	Controller	N/A	N/A	N/A
Ms. Lori Marzilli-Kahler	VP of Global Operations	N/A	N/A	N/A

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

Corporate Governance

INVO Bioscience, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.